PCR Systems, H1N1 Products Drive Q4, Full-Year Growth in Life Tech's Molecular Bio Business
January 28, 2010
PCR Systems, H1N1 Products Drive Q4, Full-Year Growth in Life Tech's Molecular Bio Business
Life Tech's sample prep and PCR products for H1N1 testing contributed approximately $15 million in revenue for the fourth quarter and about $45 million for the full year. The company also saw "continued strength in the TaqMan array business, in addition to strong demand for qPCR instrumentation and reagents."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Life Tech CEO Says Renewed Licensing Effort, Digital PCR Patents Will Spur Royalties
January 14, 2010 / PCR Insider - Ion Torrent Sales Contribute $13M to Life Tech's Q2 Top Line; Delays Hamper 5500 Revenue
August 2, 2011 / In Sequence - People in the News
May 5, 2011 / PCR Insider - Ion Torrent PGM Sales Exceed Life Tech's Expectations in Q1 while SOLiD Sales Suffer
May 3, 2011 / In Sequence - Life Technologies Launches Sequencing Upgrades as It Eyes Dx
January 11, 2011 / GenomeWeb Daily News